News | January 20, 2012

BridgePoint Licensing CTO Peripheral Vascular Products to Covidien

January 20, 2012 - BridgePoint Medical Inc. this week signed an agreement with Covidien to exclusively license the rights to its peripheral vascular products used to treat chronic total occlusions (CTO).  The agreement includes the BigBoss and Mantaray catheters and the Mantaray guidewire. The terms of the agreement were not disclosed.

“This is a fantastic achievement for BridgePoint Medical,” said Denis Harrington, CEO and president, BridgePoint Medical. “We are pleased with this transaction and expect that this agreement will be a positive development for all BridgePoint shareholders.”

The bulk of BridgePoint Medical's assets including the coronary chronic total occlusion (CTO) products, intellectual property, its employees and all other non-vascular applications will remain with the company.

BridgePoint Medical, Inc. is a privately held company established in 2006 to design, develop and commercialize new technologies and techniques to treat challenging coronary artery disease.

The Mantaray catheter was cleared by the U.S, Food and Drug Administration in August 2011. The BigBoss cathter was cleared in January 2012.

For more information: www.bridgepointmedical.com

 

Related Content

BioCardia Initiates Commercial Release of Avance Steerable Introducer
News | Catheters | October 23, 2019
BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable Introducer Sheath for...
Cook Medical Launches 2.6 Fr CXI Support Catheter
Technology | Catheters | August 23, 2019
August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI...
Biocardia Receives FDA Clearance for Avance Steerable Introducer Family
Technology | Catheters | May 16, 2019
BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable introducer...
Navitian Coronary Microcatheter Receives CE Mark Approval
News | Catheters | February 21, 2019
Navitian, the new coronary microcatheter from iVascular, recently received CE mark approval. The device was approved to...
First U.S. Patients Treated With OrbusNeich Teleport Microcatheter
News | Catheters | January 31, 2019
Cardiovascular Systems Inc. announced that the first patients in the United States were treated using the OrbusNeich...
Merit Medical Acquires Assets of Vascular Insights LLC
News | Catheters | December 18, 2018
Merit Medical Systems Inc. announced that it has acquired substantially all of the assets of Vascular Insights LLC,...
Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters | October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters | August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
Teleflex, FDA 510k clearance, TrapLiner Catheter, U.S. launch
Technology | Catheters | March 02, 2017
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
Merit Medical Systems, SwiftNINJA Steerable Microcatheter, FDA 510(k) clearance
Technology | Catheters | November 09, 2016
November 9, 2016 — Merit Medical Systems Inc.
Overlay Init